Search - tctmd.com

Displaying 241 - 260 of 479

Sort: Relevancy | Date

News Conference News EuroPCR 2015

Studies Provide Encouraging Results for DCB in Long SFA Lesions

Caitlin E. Cox

May 22, 2015

News Conference News EuroPCR 2015

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

Caitlin E. Cox

May 21, 2015

News Industry News

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

May 20, 2015

News Industry News

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

May 18, 2015

News Industry News

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

April 28, 2015

Presentation ARCH 2015

How to Approach In-Stent Restenosis

Presenter: Craig M. Walker

April 10, 2015

News Daily News

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

March 04, 2015

News Daily News

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

March 04, 2015

News Daily News

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

March 04, 2015

Presentation

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

Presenter: S Habara

March 01, 2015

News Daily News

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

L.A. McKeown

February 25, 2015

News Daily News

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

Salynn Boyles

December 15, 2014

News Daily News

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

December 14, 2014

Presentation

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Presenter: MA Magalhaes

December 11, 2014

News Daily News

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

Salynn Boyles

December 11, 2014

News Daily News

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

Todd Neale

November 17, 2014

News Daily News

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

November 06, 2014

News Daily News

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

Caitlin E. Cox

October 24, 2014

News Daily News

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

Caitlin E. Cox

October 24, 2014

News Daily News

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Caitlin E. Cox

October 24, 2014

Advertisement

Studies Provide Encouraging Results for DCB in Long SFA Lesions

PERFECT-2: Angioplasty Can Effectively Treat Erectile Dysfunction But Restenosis an Issue

Medtronic Drug-Coated Balloon for Treatment of Peripheral Arterial Disease Shows Strong Results in Long Lesions

OrbusNeich Announces Initiation of HARMONEE Stent Study in US

New Data Evaluating The Boston Scientific Eluvia™ Drug-Eluting Vascular Stent System Demonstrate 94.4 Percent Primary Patency Rate At Nine Months

How to Approach In-Stent Restenosis

Los BRF son Equiparables a los SLF en el Tratamiento de Pacientes ‘del Mundo Real’ con Reestenosis Intra-Stent

DCB与DES的“真实”支架内再狭窄患者治疗效果相当

DCB Matches DES in Treating ‘Real-World’ Patients With In-Stent Restenosis

Paclitaxel-Coated Balloon Catheter Compared With DES for DES Restenosis in Routine Clinical Practice

ZEUS Published: ZES With Personalized DAPT Bests Bare-Metal Stent in ‘Uncertain’ DES Candidates

Drug-Coated Balloon Beats Angioplasty Alone in PAD Patients

OCTOPUS: Combo of BMS Plus Paclitaxel Balloon Appears Safe But May Be Outdated

Clinical Presentation and Outcomes of Coronary In-Stent Restenosis Across 3 Stent Generations

Manifestation of In-Stent Restenosis More Tightly Linked to Patient Than Device Factors

SORT OUT III Substudy Hints at Differences in DES Efficacy Based on Diabetes Status

OCT Study Suggests Plaque ‘Capping’ Safer With BRS Than BMS

Los BRF son Mejores en Lesiones De Novo que en Lesiones Femoropoplíteas Reestenóticas

DCB在原发性病变中的表现比在再狭窄股腘动脉病变中更好

DCBs Perform Better in De Novo Compared With Restenotic Femoropopliteal Lesions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content